Dynavax Technologies Corporation (NASDAQ:DVAX) surged 8% Thursday following the announcement of encouraging topline data from ...

The company said the vaccine, called Z-1018, which was tested in patients aged 50 to 69 years, demonstrated similar antibody and T cell responses to those produced by GSK's Shingrix and had a ...